Neoadjuvant fractionated versus hypofractionated chemoradiotherapy in resectable and borderline resectable pancreatic cancer

被引：0
|
作者：
Lee, Darren
Nelson, Bailey
Rai, Shesh
Rai, Jayesh
Wang, Kyle
Sohal, Davendra
Olowokure, Olugbenga Olanrele
Rojan, Adam
Patel, Sameer H.
Wilson, Gregory
Ahmad, Syed A.
Kharofa, Jordan
机构：
[1] Univ Cincinnati, Canc Ctr, Cincinnati, OH USA
[2] Kettering Lab Complex, Cincinnati, OH USA
[3] Univ Cincinnati, Div Hematol Oncol, Canc Ctr, Cincinnati, OH USA
[4] Univ Cincinnati, Cincinnati, OH USA
[5] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4161
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [2] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [3] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [4] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    di Sebastiano, Pierluigi
    Grottola, Tommaso
    di Mola, F. Francesco
    UPDATES IN SURGERY, 2016, 68 (03) : 235 - 239
  • [5] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    Pierluigi di Sebastiano
    Tommaso Grottola
    F. Francesco di Mola
    Updates in Surgery, 2016, 68 : 235 - 239
  • [6] Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Thanikachalam, Kannan
    Damarla, Vijay
    Seixas, Trevor
    Dobrosotskaya, Irina
    Wollner, Ira
    Kwon, David
    Winters, Kenneth
    Raoufi, Mohammad
    Li, Jia
    Siddiqui, Farzan
    Khan, Gazala
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 435 - 441
  • [7] Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer
    Kumar, Rachit
    Jabbour, Salma K.
    JOURNAL OF RADIATION ONCOLOGY, 2013, 2 (04) : 353 - 367
  • [8] Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer
    Lee, Sang Hoon
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 84 (03): : 103 - 110
  • [9] Patterns of Failure Following Neoadjuvant SBRT or Fractionated Chemoradiation in Resectable and Borderline Resectable Pancreatic Cancer
    Barrord, M.
    Mierzwa, M. L.
    Ahmad, S.
    Olowokure, O.
    Sussman, J.
    Esslinger, H. R.
    Latif, T.
    Gupta, A.
    Smith, M.
    Poreddy, S.
    Kharofa, J. R., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E69 - E69
  • [10] The Outcomes of Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity Modulated Radiotherapy for Borderline Resectable Pancreatic Cancer
    Iwai, T.
    Yoshimura, M.
    Ogawa, A.
    Ono, Y.
    Masui, T.
    Nagai, K.
    Anazawa, T.
    Mizowaki, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E306 - E306
12345